Endometrial cancer (EC) is the most commonly diagnosed gynecologic malignancy.
Although early-stage EC is effectively treated surgically, commonly without adjuvant therapy …

Background Endometrial cancer is the fourth most frequent gynecological cancer and the
most frequent type of uterine cancer. There is an increase in the incidence and mortality of …

Molecular characterization of endometrial cancer and therape... : Current Opinion in Obstetrics
and Gynecology Molecular characterization of endometrial cancer and therapeutic implications …

Introduction Endometrial cancer (EC) is the only gynecologic malignancy showing
increasing trends in incidence and mortality. While standard treatment has been effective …

Endometrial carcinoma (EC) is the most commonly diagnosed gynecologic malignancy in
the western world. The majority of these cancers are curable, but a subset about 15–20% of …

Molecular genetic evidence indicates that endometrial carcinoma likely develops as the
result of a multistep process of oncogene activation and tumor suppressor gene inactivation …

Molecular characterization of endometrial cancer into subgroups has prognostic and
therapeutic implications. Further development of an integrated molecular risk profile may …

With a lifetime risk among women of 2–3%, endometrial cancer is the most common pelvic
gynecologic malignancy in industrialized countries. Approximately 75% of cases are …

Endometrial cancer (EC) is the most common gynecologic malignancy in the western world
with more than 280,000 cases per year worldwide. Prognosis for EC at early stages, when …

Endometrial cancer comprises a heterogeneous group of tumors, with distinct risk factors,
clinical presentation, histopathological features and molecular characteristics. Currently …